Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical application of expanded CD4+25+ cells.

Carl H June1, Bruce R Blazar

  • 1The Abramson Family Cancer Research Institute, The Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. cjune@mail.med.upenn.edu

Seminars in Immunology
|February 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease.

JCI insight·2019
Same author

Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation.

PloS one·2019
Same author

Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.

Nature·2019
Same author

Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2019
Same author

Validation of Minnesota acute graft-<i>versus</i>-host disease Risk Score.

Haematologica·2019
Same author

Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.

Nature·2019

Developing adoptive immunotherapy using regulatory T cells (Tregs) offers a promising path to induce immune tolerance without broad immunosuppression. This approach holds potential for treating transplant rejection, autoimmune diseases, and genetic immune disorders.

Area of Science:

  • Immunology
  • Cell Therapy

Background:

  • Inducing immunologic tolerance without harmful immunosuppression is a key goal in immunology.
  • Regulatory T cells (Tregs) possess immune suppressive activity, making them candidates for targeted therapies.

Purpose of the Study:

  • To explore the potential of adoptive immunotherapy using regulatory T cells (Tregs) for various clinical applications.
  • To outline the envisioned uses of Tregs in transplantation, autoimmune diseases, and genetic immune disorders.

Main Methods:

  • Isolation and expansion of CD4(+)CD25(+) regulatory T cells.
  • Envisioning clinical applications for adoptively transferred Tregs.

Main Results:

  • Regulatory T cells offer a potential avenue for inducing immune tolerance.

Related Experiment Videos

  • Technical challenges in manufacturing Tregs need to be addressed for widespread clinical use.

    • Conclusions:

    • Adoptive transfer of Tregs shows promise for preventing graft-versus-host disease after transplantation.
    • Treg therapy may be applied to solid organ transplantation, autoimmune disorders, and genetic immune disorders like IPEX syndrome.
    • Genetically engineered lymphocytes could enhance Treg function or replace them in specific immune disorders.